County
OCEMS
Drugs and doses23
A–C Adenosine, Albuterol, Amiodarone, Aspirin, Atropine5
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 12 mg | IV | not captured | standing | page 1 |
| Narrow-complex tachycardia | adult | 12 mg | IV | not captured | standing | page 1 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 1 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 6 mL | NEB | not captured | standing | page 2 |
| Crush injury | peds | 6 mL | NEB | not captured | standing | page 2 |
| Other | adult | 2 puff | MDI | not captured | standing | page 2 |
| Other | adult | 2 puff | MDI | not captured | standing | page 2 |
| Other | adult | 6 mL | NEB | not captured | standing | page 2 |
| Other | adult | 6 mL | NEB | not captured | standing | page 2 |
| Other | peds | 6 mL | NEB | not captured | standing | page 2 |
| Other | peds | 6 mL | NEB | not captured | standing | page 2 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 150 mg | IV | not captured | standing | page 3 |
| Other | adult | 150 mg | IV | not captured | standing | page 3 |
| Other | adult | 150 mg | IV | not captured | standing | page 3 |
| Other | adult | 150 mg | IV | not captured | standing | page 3 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 3 |
| Other | peds | 5 mg/kg | IV | not captured | standing | page 3 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 3 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 3 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 4 |
| Other | adult | 324 mg | PO | not captured | standing | page 4 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO/IM | not captured | standing | page 5 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO/IM | not captured | standing | page 5 |
| Organophosphate poisoning | adult | 2 mg | IV/IM | not captured | standing | page 5 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV/IM | not captured | standing | page 5 |
| Organophosphate poisoning | peds | 0.02 mg/kg | IV | not captured | standing | page 5 |
| Organophosphate poisoning | peds | 0.1 mg/kg | IM | not captured | standing | page 5 |
| Other | adult | 2 mg | IV | not captured | standing | page 5 |
| Other | adult | 2 mg | IM | not captured | standing | page 5 |
| Other | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 5 |
D–F Dextrose, Diphenhydramine, Epinephrine, Fentanyl4
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 250 mL | IV | not captured | standing | page 6 |
| Hypoglycemia | peds | 5 mL/kg | IV | not captured | standing | page 6 |
| Other | adult | 250 mL | IO | not captured | standing | page 6 |
| Other | peds | 5 mL/kg | IO | not captured | standing | page 6 |
| Other | peds | 5 mL/kg | IV | not captured | standing | page 6 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IM | not captured | standing | page 7 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 7 |
| Dystonic reaction | adult | 50 mg | IV/IM | not captured | standing | page 7 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 7 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.5 mg | IM | not captured | standing | page 8 |
| Allergic reaction | peds | 0.01 mg/kg | IM | not captured | standing | page 8 |
| Anaphylaxis | adult | 0.3 mg | IV/IO | not captured | standing | page 8 |
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | page 8 |
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | page 8 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 8 |
| Anaphylaxis | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 8 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 8 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 8 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 8 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 8 |
| Other | adult | 0.3 mg | IV/IO | not captured | standing | page 8 |
| Other | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 8 |
| Other | peds | 0.1 mL/kg | IV/IO | not captured | standing | page 8 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 50 mcg | IV | not captured | standing | page 9 |
| Mild to moderate pain | adult | 100 mcg | IN | not captured | standing | page 9 |
| Mild to moderate pain | adult | 50 mcg | IV/IM | not captured | standing | page 9 |
| Mild to moderate pain | peds | 2 mcg/kg | IV/IM | not captured | standing | page 9 |
| Mild to moderate pain | peds | 2 mcg/kg | IN | not captured | standing | page 9 |
G–L Glucagon, Glucose Preparations, Hydroxocobalamin, Ipratropium, Ketamine, Ketorolac, Lidocaine7
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 10 |
| Hypoglycemia | peds | 0.5 mg | IM | not captured | standing | page 10 |
Glucose Preparations
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | PO | not captured | standing | page 11 |
| Hypoglycemia | peds | 25 g | PO | not captured | standing | page 11 |
| Other | adult | 2–3 tablet | PO | not captured | standing | page 11 |
| Other | adult | 25 g | PO | not captured | standing | page 11 |
| Other | peds | 1 tablet | PO | not captured | standing | page 11 |
| Other | peds | 25 g | PO | not captured | standing | page 11 |
Hydroxocobalamin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 12 |
| Cyanide poisoning | adult | 5 g | IV/IO | not captured | standing | page 12 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 12 |
| Cyanide poisoning | peds | 70 mg/kg | IV/IO | not captured | standing | page 12 |
| Other | adult | 5 g | IV | not captured | standing | page 12 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5 mg | NEB | not captured | standing | page 2 |
| Other | adult | 0.5 mg | NEB | not captured | standing | page 2 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV | not captured | standing | page 13 |
| Mild to moderate pain | adult | 0.5 mg/kg | IM | not captured | standing | page 13 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IO/IM | not captured | standing | page 14 |
| Mild to moderate pain | peds | 0.25 mg/kg | IV/IO/IM | not captured | standing | page 14 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 15 |
| Other | adult | 1 mg/kg | IV/IO | not captured | standing | page 15 |
| Other | adult | 1 mg/kg | not captured | not captured | standing | page 15 |
| Other | adult | 1–1.5 mg/kg | not captured | not captured | standing | page 15 |
| Other | adult | 20 mg | IO | not captured | standing | page 15 |
| Other | adult | 20 mg | not captured | not captured | standing | page 15 |
| Other | peds | 0.5 mg/kg | IO | not captured | standing | page 15 |
| Other | peds | 0.5 mg/kg | not captured | not captured | standing | page 15 |
| Other | peds | 1 mg/kg | IV/IO | not captured | standing | page 15 |
| VF / pulseless VT | peds | 1 mg/kg | not captured | not captured | standing | page 15 |
M–O Midazolam, Morphine, Naloxone, Nitroglycerin, Ondansetron, Oral Glucose6
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IM/IN | not captured | standing | page 16 |
| Other | peds | 0.1 mg/kg | IV/IO/IN | not captured | standing | page 16 |
| Procedural sedation | adult | 5 mg | IV | not captured | standing | page 16 |
| Procedural sedation | adult | 5 mg | IN | not captured | standing | page 16 |
| RSI induction | adult | 5 mg | IV | not captured | standing | page 16 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 16 |
| Seizure | adult | 5 mg | IV/IN | not captured | standing | page 16 |
| Seizure | peds | 0.1 mg/kg | IV/IN | not captured | standing | page 16 |
| Seizure | peds | 0.2 mg/kg | IM | not captured | standing | page 16 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 5 mg | IV | not captured | standing | page 17 |
| Mild to moderate pain | adult | 5 mg | IO | not captured | standing | page 17 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 17 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 18 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 18 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 18 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 19 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 19 |
| Other | adult | 0.8 mg | SL | not captured | standing | page 19 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV | not captured | standing | page 21 |
| Nausea / vomiting | adult | 8 mg | PO | not captured | standing | page 21 |
| Nausea / vomiting | adult | 8 mg | ODT | not captured | standing | page 21 |
| Nausea / vomiting | peds | 4 mg | PO | not captured | standing | page 21 |
| Nausea / vomiting | peds | 4 mg | ODT | not captured | standing | page 21 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2–3 tablet | PO | not captured | standing | page 11 |
| Other | peds | 1 tablet | PO | not captured | standing | page 11 |
S–Z Sodium Bicarbonate1
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 50 mL | IV/IO | not captured | standing | page 23 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 23 |
| Crush injury | adult | 50 mL | IV/IO | not captured | standing | page 23 |
| Crush injury | peds | 1 mEq/kg | IV/IO | not captured | standing | page 23 |
Cite this
OCEMS, United States EMS Protocol Census. 116 dose entries, effective 2026-06-01.
https://protoquiz.com/census/agencies/ocems/
The census is free and not for sale. Only public agencies are named.